Book contents
- Medication-Resistant Epilepsy
- Medication-Resistant Epilepsy
- Copyright page
- Dedication
- Contents
- Contributors
- Chapter 1 The Natural History of Epilepsy
- Chapter 2 Challenges in Identifying Medication-Resistant Epilepsy
- Chapter 3 International League Against Epilepsy’s Definition of Medication-Resistant Epilepsy
- Chapter 4 The Economic Impact of Medication-Resistant Epilepsy
- Chapter 5 Social Consequences of Medication-Resistant Epilepsy
- Chapter 6 Mortality and Morbidity of Medication-Resistant Epilepsy
- Chapter 7 Models for Medication-Resistant Epilepsy
- Chapter 8 Neurobiology of Medication-Resistant Epilepsy
- Chapter 9 Genetic Causes of Medication-Resistant Epilepsy
- Chapter 10 Malformations of Cortical Development as Causes of Medication-Resistant Epilepsy
- Chapter 11 Hippocampal Sclerosis as a Cause of Medication-Resistant Epilepsy
- Chapter 12 Autoimmune Causes of Medication-Resistant Epilepsy
- Chapter 13 Medication-Resistant Epilepsy Syndromes in Children
- Chapter 14 Medication-Resistant Epilepsy in Adults
- Chapter 15 Approach to the Treatment of Medication-Resistant Epilepsy
- Chapter 16 Pharmacotherapy for Medication-Resistant Epilepsy
- Chapter 17 Reproductive Health for Women with Medication-Resistant Epilepsy
- Chapter 18 Resective Surgery for Medication-Resistant Epilepsy
- Chapter 19 Ablative Surgery for Medication-Resistant Epilepsy
- Chapter 20 Stimulation Treatment for Medication-Resistant Epilepsy
- Chapter 21 Diet Therapy for Medication-Resistant Epilepsy
- Chapter 22 Botanical Treatments for Medication-Resistant Epilepsy
- Chapter 23 Psychiatric Comorbidities in Medication-Resistant Epilepsy
- Index
- References
Chapter 10 - Malformations of Cortical Development as Causes of Medication-Resistant Epilepsy
Published online by Cambridge University Press: 20 August 2020
- Medication-Resistant Epilepsy
- Medication-Resistant Epilepsy
- Copyright page
- Dedication
- Contents
- Contributors
- Chapter 1 The Natural History of Epilepsy
- Chapter 2 Challenges in Identifying Medication-Resistant Epilepsy
- Chapter 3 International League Against Epilepsy’s Definition of Medication-Resistant Epilepsy
- Chapter 4 The Economic Impact of Medication-Resistant Epilepsy
- Chapter 5 Social Consequences of Medication-Resistant Epilepsy
- Chapter 6 Mortality and Morbidity of Medication-Resistant Epilepsy
- Chapter 7 Models for Medication-Resistant Epilepsy
- Chapter 8 Neurobiology of Medication-Resistant Epilepsy
- Chapter 9 Genetic Causes of Medication-Resistant Epilepsy
- Chapter 10 Malformations of Cortical Development as Causes of Medication-Resistant Epilepsy
- Chapter 11 Hippocampal Sclerosis as a Cause of Medication-Resistant Epilepsy
- Chapter 12 Autoimmune Causes of Medication-Resistant Epilepsy
- Chapter 13 Medication-Resistant Epilepsy Syndromes in Children
- Chapter 14 Medication-Resistant Epilepsy in Adults
- Chapter 15 Approach to the Treatment of Medication-Resistant Epilepsy
- Chapter 16 Pharmacotherapy for Medication-Resistant Epilepsy
- Chapter 17 Reproductive Health for Women with Medication-Resistant Epilepsy
- Chapter 18 Resective Surgery for Medication-Resistant Epilepsy
- Chapter 19 Ablative Surgery for Medication-Resistant Epilepsy
- Chapter 20 Stimulation Treatment for Medication-Resistant Epilepsy
- Chapter 21 Diet Therapy for Medication-Resistant Epilepsy
- Chapter 22 Botanical Treatments for Medication-Resistant Epilepsy
- Chapter 23 Psychiatric Comorbidities in Medication-Resistant Epilepsy
- Index
- References
Summary
Malformations of cortical development (MCD) are by now well recognized causes of neurodevelopmental disorders and epilepsy [1]. The precise etiological mechanisms, clinical features and course vary as patients present with a wide range of developmental disorders, associated somatic and cortical malformations, and epilepsy. Specific clinical phenotypes can be recognized in a proportion of patients based on common clinical and imaging features. Furthermore, genetic testing allows for specific phenotype–genotype classification. However, as with many genetic disorders, the phenotypic variability is large, presenting a challenge to the diagnosis and clinical management of these patients.
- Type
- Chapter
- Information
- Medication-Resistant EpilepsyDiagnosis and Treatment, pp. 79 - 86Publisher: Cambridge University PressPrint publication year: 2020